Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-11-14

FDA Approved: MORPHINE SULFATE — Original Application (PAI Holdings, LLC dba PAI Pharma)

View source ↗

Summary

FDA approved Morphine Sulfate as an Original Application generic product (ANDA 206573) for PAI Holdings dba PAI Pharma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MORPHINE SULFATE (MORPHINE SULFATE)

Snippet

ORIG AP for MORPHINE SULFATE (MORPHINE SULFATE)